INOVIO PHARMACEUTICALS, INC. - FORM 10-K - EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. - March 16, 2011

Attached files

file filename
10-K - FORM 10-K - INOVIO PHARMACEUTICALS, INC.d10k.htm
EX-31.2 - CERTIFICATION OF THE CFO - INOVIO PHARMACEUTICALS, INC.dex312.htm
EX-10.5 - EMPLOYMENT AGREEMENT - INOVIO PHARMACEUTICALS, INC.dex105.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - INOVIO PHARMACEUTICALS, INC.dex231.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INOVIO PHARMACEUTICALS, INC.dex211.htm
EX-31.1 - CERTIFICATION OF THE CEO - INOVIO PHARMACEUTICALS, INC.dex311.htm

Exhibit 32.1

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Inovio Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
March 16, 2011     /s/    J. JOSEPH KIM        
   

J. Joseph Kim

President, Chief Executive Officer and Director

(Principal Executive Officer)

      /s/    PETER KIES        
   

Peter Kies

Chief Financial Officer

(Principal Financial and Accounting Officer)

INOVIO PHARMACEUTICALS, INC. Reports